GUT : 酒精通过FoxO1调节肝细胞中的miR-148a以及通过TXNIP过表达来促进肝细胞凋亡

2018-11-19 MedSci MedSci原创

酒精性肝病(ALD)是慢性肝病死亡的主要原因。然而,其发病机制尚未完全明确。微小RNA(miRNA)是肝脏疾病进展的关键因素。该研究调查了ALD失调的肝细胞丰富的miRNA,其对肝细胞损伤的影响和潜在的基础。

目的
酒精性肝病(ALD)是慢性肝病死亡的主要原因。然而,其发病机制尚未完全明确。微小RNA(miRNA)是肝脏疾病进展的关键因素。该研究调查了ALD失调的肝细胞丰富的miRNA,其对肝细胞损伤的影响和潜在的基础。

方法
使用酒精性肝炎(AH)人和动物肝脏样品和肝细胞来检测miR-148a水平。使用慢病毒将Pre-miR-148a在体内特异性递送至肝细胞。并在细胞模型中进行免疫印迹,荧光素酶基因测定,染色质免疫沉淀和免疫荧光测定

结果
miRNA谱和PCR分析使研究人员发现AH患者肝脏中miR-148a显着减少。在接受Lieber-DeCarli酒精饮食或饮酒的小鼠中,miR-148a水平也显着降低。在培养的肝细胞和小鼠肝脏中,酒精暴露抑制FoxO1表达,其与miR-148a水平相关并且在人AH样品中显着降低。FoxO1被鉴定为MIR148A的转录因子激活。MiR-148a直接抑制硫氧还蛋白相互作用蛋白(TXNIP)的表达。因此,用乙醇处理肝细胞导致TXNIP过表达,激活NLRP3炎性体和半胱天冬酶-1介导的焦磷酸化。向小鼠的肝细胞特异性递送miR-148a消除了酒精诱导的TXNIP过表达和炎性体激活,减轻了肝损伤。

结论 
酒精通过FoxO1降低肝细胞中miR-148a的表达,促进TXNIP过表达和NLRP3炎性体激活,诱导肝细胞凋亡。

原始出处

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1863399, encodeId=3adc18633994f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Sep 04 15:35:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958187, encodeId=4982195818ee2, content=<a href='/topic/show?id=48a294126c0' target=_blank style='color:#2F92EE;'>#过表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94126, encryptionId=48a294126c0, topicName=过表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Fri Feb 15 10:35:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930661, encodeId=1907193066125, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Jan 09 07:35:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340287, encodeId=9a96134028e2f, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533939, encodeId=53681533939ee, content=<a href='/topic/show?id=132ee62484' target=_blank style='color:#2F92EE;'>#FOXO1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7624, encryptionId=132ee62484, topicName=FOXO1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82812497085, createdName=许安, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2019-09-04 xjy02
  2. [GetPortalCommentsPageByObjectIdResponse(id=1863399, encodeId=3adc18633994f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Sep 04 15:35:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958187, encodeId=4982195818ee2, content=<a href='/topic/show?id=48a294126c0' target=_blank style='color:#2F92EE;'>#过表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94126, encryptionId=48a294126c0, topicName=过表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Fri Feb 15 10:35:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930661, encodeId=1907193066125, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Jan 09 07:35:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340287, encodeId=9a96134028e2f, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533939, encodeId=53681533939ee, content=<a href='/topic/show?id=132ee62484' target=_blank style='color:#2F92EE;'>#FOXO1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7624, encryptionId=132ee62484, topicName=FOXO1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82812497085, createdName=许安, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2019-02-15 lq1767
  3. [GetPortalCommentsPageByObjectIdResponse(id=1863399, encodeId=3adc18633994f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Sep 04 15:35:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958187, encodeId=4982195818ee2, content=<a href='/topic/show?id=48a294126c0' target=_blank style='color:#2F92EE;'>#过表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94126, encryptionId=48a294126c0, topicName=过表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Fri Feb 15 10:35:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930661, encodeId=1907193066125, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Jan 09 07:35:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340287, encodeId=9a96134028e2f, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533939, encodeId=53681533939ee, content=<a href='/topic/show?id=132ee62484' target=_blank style='color:#2F92EE;'>#FOXO1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7624, encryptionId=132ee62484, topicName=FOXO1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82812497085, createdName=许安, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2019-01-09 smallant2002
  4. [GetPortalCommentsPageByObjectIdResponse(id=1863399, encodeId=3adc18633994f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Sep 04 15:35:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958187, encodeId=4982195818ee2, content=<a href='/topic/show?id=48a294126c0' target=_blank style='color:#2F92EE;'>#过表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94126, encryptionId=48a294126c0, topicName=过表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Fri Feb 15 10:35:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930661, encodeId=1907193066125, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Jan 09 07:35:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340287, encodeId=9a96134028e2f, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533939, encodeId=53681533939ee, content=<a href='/topic/show?id=132ee62484' target=_blank style='color:#2F92EE;'>#FOXO1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7624, encryptionId=132ee62484, topicName=FOXO1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82812497085, createdName=许安, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1863399, encodeId=3adc18633994f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Sep 04 15:35:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958187, encodeId=4982195818ee2, content=<a href='/topic/show?id=48a294126c0' target=_blank style='color:#2F92EE;'>#过表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94126, encryptionId=48a294126c0, topicName=过表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Fri Feb 15 10:35:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930661, encodeId=1907193066125, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Jan 09 07:35:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340287, encodeId=9a96134028e2f, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533939, encodeId=53681533939ee, content=<a href='/topic/show?id=132ee62484' target=_blank style='color:#2F92EE;'>#FOXO1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7624, encryptionId=132ee62484, topicName=FOXO1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82812497085, createdName=许安, createdTime=Tue Nov 20 23:35:00 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2018-11-20 许安

相关资讯

Hepatol Res:危重症肝硬化患者的急性呼吸窘迫综合征的危险因素和结果

急性肝衰竭和休克是导致ARDS发展的危险因素,而肝硬化和酒精的病因则不是导致ARDS发展的危险因素。患有ARDS的肝硬化患者死亡率明显增加。早期识别和治疗感染对于改善患者的生存是重要的。

J Hepatol:饮酒会增加日后患严重肝病的风险

年轻男性的饮酒量与严重的肝脏疾病的风险增加有关。患病风险是剂量依赖性的,有阈值效应。目前有关男性安全饮酒的指南可能需要修改